β地中海贫血主要型的心血管磁共振:超越T2*
本综述概述心血管磁共振(CMR)在β地中海贫血主要型(β-TM)患者中的应用,除T2*测量指导铁螯合治疗外,还涵盖心肌应变、参数映射(T1、T2、细胞外容积)和晚期钆增强(LGE)等新兴生物标志物在诊断、预后和随访中的潜在价值。
要点
- CMR的T2*弛豫时间测量是评估心肌铁过载和指导铁螯合治疗的首选诊断方法。
- 即使经调整的螯合治疗降低了心肌铁过载,心力衰竭仍是β-TM患者发病和死亡的主要原因。
- 心肌应变、参数映射(T1、T2、细胞外容积)和LGE等新兴CMR生物标志物可能改善β-TM患者的整体管理。
核心结论
- CMR在β-TM中的应用已超越T2*测量指导螯合治疗,新兴CMR成像生物标志物可能改善β-TM患者的整体管理。
研究设计与样本
- 综述,检索范围与纳入文献原文未报告。
诊断标准与关键数值
- CMR通过测量T2*弛豫时间评估心肌铁过载并指导铁螯合治疗,为诊断首选方法;综述汇总的新兴生物标志物包括心肌应变、参数映射(T1、T2、细胞外容积)和晚期钆增强(LGE)测量。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Β-thalassemia major (TM) patients underwent regular transfusions to prevent complications of chronic anemia. However, these regular transfusions result in progressive iron accumulation in vital organs, including the heart. Myocardial iron overload can lead to cardiac dysfunction and ultimately to heart failure. Diagnosis of cardiac dysfunction in β-TM patients is usually made through clinical examination, electrocardiogram, and echocardiography. Cardiac magnetic resonance (CMR), through the measurement of T2* relaxation time, represents the diagnostic modality of choice for assessing myocardial iron overload and guiding the iron chelation therapy. Despite a tailored chelation therapy reducing myocardial iron overload, heart failure remains the leading cause of morbidity and mortality even in well-treated β-TM patients. Advances in CMR, including myocardial strain, parametric mapping (T1, T2, and extracellular volume), and late gadolinium enhancement (LGE) measurements, have expanded its role in the diagnosis, prognosis, and follow-up of these patients. This review seeks to offer a thorough overview of the potential uses of CMR in β-TM, extending beyond the established role of T2* measurement in guiding chelation therapy. It delves into the emerging applications of new CMR imaging biomarkers that could improve the overall management of β-TM patients.
引用
- Meloni A, Saba L, Cademartiri F, et al. Cardiovascular magnetic resonance in β-thalassemia major: beyond T2. Radiol Med. 2024. PMID: 39511065. doi:10.1007/s11547-024-01916-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。